Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
Vaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23% at one point. Vaxart’s average session volume was about 1.6 million. Friday premarket’s ...
The Biomedical Advanced Research and Development Authority (BARDA) has issued an $8.6 million contract to OraSure Technologies Inc (NASDAQ: OSUR) for developing a 2nd generation Ebola test on the ...
Operation Warp Speed, initially funded with about $10 billion from the CARES Act (Coronavirus Aid, Relief, and Economic Security) passed by the United States Congress on March 27, 2020, [1] was an interagency program that includes components of the Department of Health and Human Services, including the Centers for Disease Control and Prevention ...
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the Department of Health and Human Services. [1] Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that ...
A new House bill would ban health insurers from imposing arbitrary time limits on patients under anesthesia — days after Anthem Blue Cross Blue Shield only backed off the move amid outcry. “We ...
The Center for Scientific Review (CSR) is the portal for United States National Institutes of Health (NIH) grant applications and their review for scientific merit. The CSR organizes the peer review groups or study sections that evaluate the majority (76%) of the research grant applications sent to NIH. [ 1 ]
The government should conduct a review of military-civilian collaborative efforts, mandate military-civilian collaboration on biodefense (including research regarding force protection), clarify parameters for military support to civilian authorities in response to a domestic biological attack, and update and implement military biodefense doctrine.